NPCE vs TMUS · rev $22.8M vs P/E 19, rev $22.79B
Neuropace Inc (NPCE) versus T-Mobile US Inc (TMUS) — a side-by-side from cached financials, not a winner call.
Neuropace Inc (NPCE) is a medical devices company listed on US.
T-Mobile US Inc (TMUS) is a telecom services company listed on NASDAQ. It is led by Mike Sievert.
Latest reported NPCE revenue for 2026-06-30 was $22.8M. Net income was -$6.2M. Revenue was up 3.4% from 2026-03-31 to 2026-06-30. NPCE currently screens at market cap $312.2M.
Latest reported TMUS revenue for 2026-06-30 was $22.79B. Net income was $3.24B. Revenue was down 1.4% from 2026-03-31 to 2026-06-30. TMUS currently screens at market cap $196.21B and trailing P/E 19.3.
NPCE currently screens at market cap $312.2M. TMUS currently screens at market cap $196.21B and trailing P/E 19.3.
Not investment advice. Open the NPCE and TMUS stock pages for the full models.
Not investment advice.